Colon cancer is the 3rd most common cancer in the United States. Unfortunately, most patients present with Stage III or IV disease and disease recurrence is high despite advanced in systemic therapies. Despite evidence that gadoxetic acid-enhanced MRI is superior for the detection and diagnosis of colon cancer liver metastases, computed tomography remains the recommended staging and surveillance modality. The purpose of this abstract is to synthesize and analyze the evidence regarding the accuracy of liver MRI to stage and surveil CCLM, and to identify knowledge gaps to inform future research on staging and surveillance imaging for CCLM.
This abstract and the presentation materials are available to members only; a login is required.